stella
beta
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates — Stella
Recruiting
Back to Rectal Adenocarcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
University of Colorado Cancer Center, Aurora, Colorado
University of Rochester Medical Center, Rochester, New York
Oregon Health and Sciences University, Portland, Oregon
View full record on ClinicalTrials.gov